Similar articles

• Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.

  HAMBLY CK, ROBERTSON TI. HAMBLY CK, et al. Med J Aust. 1955 Jun 18;42(1 25):900-11. doi: 10.5694/j.1326-5377.1955.tb38360.x. Med J Aust. 1955. PMID: 13243982 No abstract available.
• Treatment of lymphomatous diseases with triethylene melamine.

  MEYER LM, SCHWARTZ SO, SAWITSKY A, BEYERS MR, RITZ ND, BRAHIN C, DIEFENBACH W, KLEINSCHMIDT W, FRIEDMAN I. MEYER LM, et al. Acta Med Scand Suppl. 1952;272:1-36. Acta Med Scand Suppl. 1952. PMID: 13039963 No abstract available.
• [Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma].

  HAEHNER E, HEINEN W, LOOSEN H, SCHMIDT H. HAEHNER E, et al. Med Klin. 1954 May 21;49(21):853-4; passim. Med Klin. 1954. PMID: 13164965 Undetermined Language. No abstract available.
• TRIETHYLENE MELAMINE IN THE CONTROL OF HODGKIN'S DISEASE AND THE LEUKEMIAS. IV. CLINICAL REPORTS, 1959-62.

  SAMPEY JR. SAMPEY JR. Am J Pharm Sci Support Public Health. 1963 Dec;135:451-7. Am J Pharm Sci Support Public Health. 1963. PMID: 14101404 Review. No abstract available.
• [Cases of familial leukemia-lymphoma in Szabolcs-Szatmár-Bereg County].

  Jakó J, Szerafin L, Póth I, Nagy P, Smanykó D, Babicz T. Jakó J, et al. Orv Hetil. 1992 Jan 19;133(3):147-8, 153. Orv Hetil. 1992. PMID: 1734343 Review. Hungarian.